Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 18, Issue 7, 2000, Pages 1525-1532

  Woo, Michael H ^a   Hak, Lawrence J ^a   Storm, Michael C ^a   Sandlund, John T ^a   Ribeiro, Raul C ^a   Rivera, Gaston K ^a   Rubnitz, Jeffrey E ^a   Harrison, Patricia L ^a   Wang, Bo ^a   Evans, William E ^a   Pui, Ching Hon ^a   Relling, Mary V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLERGIC REACTION; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ERWINIA; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034117076     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.7.1525     Document Type: Article

References (32)

1. Capizzi RL, Bertino JR, Skeel RT, et al: L-asparaginase: Clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med 74:893-901, 1971
2. Haskell CM, Canellos GP: 1-asparaginase resistance in human leukemia-asparagine synthetase. Biochem Pharmacol 18:2578-2580, 1969
3. Asselin BL, Whitin JC, Coppola DJ, et al: Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 11:1780-1786, 1993
4. Evans WE, Tsiatis A, Rivera G, et al: Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 49:1378-1383, 1982
5. Billett AL, Carls A, Gelber RD, et al: Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer 70:201-206, 1992
6. Killander D, Dohlwitz A, Engstedt L, et al: Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer 37:220-228, 1976
7. Oettgen HF, Stephenson PA, Schwartz MK, et al: Toxicity of E. coli L-asparaginase in man. Cancer 25:253-278, 1970
8. Woo MH, Hak LJ, Storm MC, et al: Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia 12:1527-1533, 1998
9. Peterson RG, Handschumacher RE, Mitchell MS: Immunological responses to L-asparaginase. J Clin Invest 50:1080-1090, 1971
10. Cheung NK, Chau IY, Coccia PF: Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol 8:99-104, 1986
11. Nesbit M, Chard R, Evans A, et al: Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol 1:9-13, 1979
12. Pratt CB, Simone JV, Zee P, et al: Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J Pediatr 77:474-483, 1970
13. Pratt CB, Choi SI, Holton CP: Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia. Am J Dis Child 121:406-409, 1971
14. Jaffe N, Traggis D, Das L, et al: L-asparaginase in the treatment of neoplastic diseases in children. Cancer Res 31:942-949, 1971
15. Jaffe N, Traggis D, Das L, et al: Favorable remission induction rate with twice weekly doses of L-asparaginase. Cancer Res 33:1-4, 1973
16. Leventhal BG, Henderson ES: Therapy of acute leukemia with drug combinations which include asparaginase. Cancer 28:825-829, 1971
17. Evans WE, Tsiatis A, Rivera G, et al: Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 49:1378-1383, 1982
18. Land VJ, Sutow WW, Fernbach DJ, et al: Toxicity of L-asparaginase in children with advanced leukemia. Cancer 30:339-347, 1972
19. Jacquillat C, Weil M, Bussel A, et al: Treatment of acute leukemia with L-asparaginase: Preliminary results on 84 cases. Recent Results Cancer Res 33:263-278, 1970
20. Larson RA, Fretzin MH, Dodge RK, et al: Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia 12:660-665, 1998
21. Pui C-H, Relling MV, Behm FG, et al: L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia 9:1680-1684, 1995
22. Relling MV, Yanishevski Y, Nemec J, et al: Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 12:346-352, 1998
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
25. Gentili D, Conter V, Rizzari C, et al: L-asparagine depletion in plasma and cerebrospinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase. Ann Oncol 7:725-730, 1996
26. Dellinger CT, Miale TD: Comparison of anaphylactic reactions to asparaginase derived from Escherichla coli and from Erwinia cultures. Cancer 38:1843-1846, 1976
27. Steuber CP, Levy GJ, Nix WL, et al: Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia. Med Pediatr Oncol 5:33-38, 1978
28. Ertel IJ, Nesbit ME, Hammond D, et al: Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: A report from Childrens Cancer Study Group. Cancer Res 39:3893-3896, 1979
29. Ohnuma T, Holland JF, Meyer P: Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer 30:376-381, 1972
30. King OY, Wilbur JR, Mumford DM, et al: Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase. Cancer 33:611-614, 1974
31. Pui C-H, Relling MV, Rivera GK, et al: Epipodophyllotoxin-related acute myeloid leukemia: A study of 35 cases. Leukemia 9:1990-1996, 1995
32. Winick NJ, McKenna RW, Shuster JJ, et al: Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11:209-217, 1993